Join a seasoned U.S. Food and Drug Administration (FDA) Investigator for an overview of how to "stress test" your electronic source (eSource) documents to ensure that they are compliant with FDA regulations and current guidance. This session offers a brief overview of regulatory requirements governing the creation, maintenance, and storage of electronic data at clinical sites and reviews some examples of shortcomings observed in FDA inspections that resulted in FDA Form 483s (Notice of Inspectional Observations) and even Warning Letters. We will also review different types and sources of eSource documentation, including digital health technology, registries used to source real-world data, and electronic medical records, and review common pitfalls associated with them. After the presentation, there will be a live Q&A opportunity.

CEU: 1.00 ACRP

Speaker:

• Barbara Wright, JD, Senior Advisor, Office of Bioresearch Monitoring Inspectorate, Office of Inspections & Investigations, FDA